Steven Cohen’s Monte Rosa Therapeutics GLUE Stock Holding History
Bought
Maintained
Sold
Other funds holding GLUE
BBA
Steven Cohen's GLUE Position: Q3 2026 in Review
Steven Cohen opened a new position in Monte Rosa Therapeutics (GLUE) in Q3 2026: 770,673 shares worth $9.19M. The stake represents 0.01% of the portfolio and ranks #1406 among its holdings. This is a return to the name: Steven Cohen previously reported a position in GLUE as recently as Q3 2025.
Steven Cohen first reported a position in GLUE in Q2 2021 and has held it in 4 quarters since. 188 funds tracked by Wall St. Rank hold GLUE as of Q3 2026.
- Steven Cohen held 770,673 shares of Monte Rosa Therapeutics worth $9.19M as of Q3 2026.
- Monte Rosa Therapeutics was a new Steven Cohen position in Q3 2026.
- Monte Rosa Therapeutics made up 0.01% of Steven Cohen's portfolio in Q3 2026, its #1406 holding.
- Steven Cohen first reported a position in Monte Rosa Therapeutics in Q2 2021 and has held it in 4 quarters since.
- 188 funds tracked by Wall St. Rank held Monte Rosa Therapeutics as of Q3 2026.
Based on Point72 Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.